MONTALI, Anna
 Distribuzione geografica
Continente #
NA - Nord America 2.412
EU - Europa 618
AS - Asia 282
SA - Sud America 20
AF - Africa 12
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.345
Nazione #
US - Stati Uniti d'America 2.391
IT - Italia 192
IN - India 144
SE - Svezia 143
CN - Cina 109
FI - Finlandia 77
DE - Germania 73
UA - Ucraina 51
IE - Irlanda 29
CA - Canada 20
SG - Singapore 18
BG - Bulgaria 17
AR - Argentina 16
TG - Togo 11
BE - Belgio 8
NL - Olanda 8
RO - Romania 8
TR - Turchia 8
GB - Regno Unito 7
CL - Cile 3
FR - Francia 2
HK - Hong Kong 2
BR - Brasile 1
DK - Danimarca 1
ES - Italia 1
EU - Europa 1
IR - Iran 1
MX - Messico 1
RU - Federazione Russa 1
ZA - Sudafrica 1
Totale 3.345
Città #
Fairfield 384
Ashburn 218
Chandler 210
Woodbridge 181
Ann Arbor 142
Houston 133
Seattle 131
Cambridge 112
Wilmington 110
Beijing 85
Rome 82
Princeton 79
Plano 58
Fremont 49
Dearborn 40
Boston 38
Lawrence 38
San Diego 32
Dublin 29
Millbury 26
Helsinki 24
San Paolo di Civitate 24
Des Moines 22
Jacksonville 20
Sofia 17
Federal 16
New York 16
Andover 15
Pune 12
Lomé 11
Ottawa 11
Norwalk 9
Istanbul 8
Toronto 8
Singapore 7
Falls Church 6
Milan 6
Berlin 5
Brussels 5
Frankfurt am Main 5
Redmond 5
Boardman 4
Bremen 4
Bühl 4
Kunming 4
Nanjing 4
San Mateo 4
Fuzhou 3
Naples 3
Phoenix 3
Amsterdam 2
Casarile 2
Florence 2
Foggia 2
Gelsenkirchen 2
Guangdong 2
Hefei 2
Hong Kong 2
Indiana 2
Leawood 2
London 2
Redwood City 2
Sacramento 2
San Francisco 2
Shanghai 2
Waanrode 2
Yellow Springs 2
Aiello Del Sabato 1
Arnsberg 1
Bagnacavallo 1
Bari 1
Bonndorf 1
Buffalo 1
Chengdu 1
Chongqing 1
Copenhagen 1
Den Haag 1
Duncan 1
Etobicoke 1
Grottaferrata 1
Guangzhou 1
Hebei 1
Humanes de Madrid 1
Latina 1
Laurel 1
Los Angeles 1
Mexico City 1
Miami 1
Napoli 1
Nurallào 1
Pescara 1
Rho 1
Saint Louis 1
San Benedetto Ullano 1
Santiago 1
Silverton 1
Southend 1
Westminster 1
Wuhan 1
Totale 2.528
Nome #
Effects of angiopoietin-like protein 3 deficiency on postprandial lipid and lipoprotein metabolism 138
Evaluation of polygenic determinants of non-alcoholic fatty liver disease (NAFLD) by a candidate genes resequencing strategy 99
Spectrum of mutations and long-term clinical outcomes in genetic chylomicronemia syndromes 97
Atherogenic dyslipidemia in children: evaluation of clinical, biochemical and genetic aspects. 92
Genetic variants in adipose triglyceride lipase influence lipid levels in familial combined hyperlipidemia 87
Association of RXR-Gamma Gene Variants with Familial Combined Hyperlipidemia: Genotype and Haplotype Analysis 87
Non-alcoholic fatty liver disease and subclinical atherosclerosis: a comparison of metabolically- versus genetically-driven excess fat hepatic storage 85
C242T polymorphism of NADPH oxidase p22phox and recurrence of cardiovascular events in coronary artery disease 85
Serum adiponectin is decreased in patients with familial combined hyperlipidemia and normolipaemic relatives and is influenced by lipid-lowering treatment 82
Contribution of mutations in low density lipoprotein receptor (LDLR) and lipoprotein lipase (LPL) genes to familial combined hyperlipidemia (FCHL): A reappraisal by using a resequencing approach 81
A polymorphism in the cyclooxygenase 2 gene as an inherited protective factor against myocardial infarction and stroke 79
Angptl3 deficiency is associated with increased insulin sensitivity, lipoprotein lipase activity, and decreased serum free fatty acids 78
5-lipoxygenase variant genotype as an inherited risk factor for myocardial infarction modifiable by n-3 fatty acid supplementation 77
PON1 L55M polymorphism is not a predictor of coronary atherosclerosis either alone or in combination with Q192R polymorphism in an Italian population 76
Analysis of Children and Adolescents with Familial Hypercholesterolemia 75
A novel splicing mutation in the ABCA1 gene, causing Tangier disease and familial HDL deficiency in a large family 74
Comparison of atorvastatin versus fenofibrate in reaching lipid targets and influencing biomarkers of endothelial damage in patients with familial combined hyperlipidemia 73
Clinical and biochemical characterisation of patients with autosomal recessive hypercholesterolemia (ARH) 73
Functional and morphological vascular changes in subjects with familial combined hypolipidemia: An exploratory analysis 72
Angiotensin-converting enzyme gene polymorphism is not associated with coronary atherosclerosis and myocardial infarction in a sample of Italian patients 68
Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study 67
Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN) 66
Continuous case finding of familial hypercholesterolemia (FH): screening of a cohort of italian children with hypercholesterolemia. 64
Functional rs20417 SNP (-765G > C) of Cyclooxygenase-2 Gene Does Not Predict the Risk of Recurrence of Ischemic Events in Coronary Patients: Results of a 7-Year Prospective Study 63
Evolving trend in the management of heterozygous familial hypercholesterolemia in Italy: a retrospective, single center, observational study 63
Plasma cholesterol response to a change in dietary fat intake: A collaborative twin study 61
Detection of familial hypercholesterolemia in a cohort of children with hypercholesterolemia: Results of a family and DNA-based screening 60
The gln-Arg192 polymorphism of human paraoxonase gene is not associated with coronary artery disease in italian patients 60
Genetic determinants of dyslipidemia associated with the insulin resistance syndrome (IRS) 55
Circulating miR-33a and miR-33b increase in familial hypercholesterolemia in paediatric age 52
Lack of association between arterial blood pressure and erythrocyte fatty acid composition in an Italian population sample 50
Insulin receptor substrate-1 gene variant in extracoronary atherosclerosis: Evidence for an association with increased risk of ischemic stroke 47
Plasma non-cholesterol sterols: a useful diagnostic tool in pediatric hypercholesterolemia. 47
null 45
Refinement of pathogenicity classification of variants associated with familial hypercholesterolemia: implications for clinical diagnosis 45
Interleukin-1 gene cluster polymorphisms and risk of coronary artery disease 44
An improved gas liquid chromatographic method for the determination of fecal neutral sterols 44
Analisi mutazionale dei geni ApoA1 e LPL nella dislipidemia aterogena in età pediatrica 44
Comparison of subjective and objective methods of estimating lipid intake 43
Lack of association of the common TaqIB polymorphism in the cholesterol ester transfer protein gene with angiographically assessed coronary atherosclerosis. 42
Uric acid levels in metabolic syndrome, type 2 diabetes and familial combined hyperlipidemia: a comparison 41
Mutations in the ANGPTL3 gene and familial combined hypolipidemia: A clinical and biochemical characterization 40
Erythrocyte fatty acid composition and gallstone disease: results of an epidemiological survey 40
null 39
Subclinical atherosclerosis in systemic lupus erythematosus and antiphospholipid syndrome: Focus on β2GPI-Specific T cell response 38
Phenotype expression in Italian families with Familial Combined Hypercholesterolemia (FCHL): The Familial Combined Hypercholesterolemia Genetic Study 37
The metabolic basis of a new form of recessive hypercholesterolemia: the "FH-like" hypercholesterolemia 37
The molecular basis of Lecithin Choleesterol Acyltransferase Deficiency Sindrome. A comprehensive study of molecular and biochemical findings in 13 italian families 36
A common mutation in the insulin receptor substrate-1 gene is a genetic marker for the insulin resistance syndrome in patients with coronary artery disease 36
Genome wide search for linkage mapping of susceptibility genes for familial combined hyperlipidemia (FCHL) 35
Does intervention on glycemic control influence HDL cholesterol levels in type 2 diabetes? A pilot study 31
Il ruolo dei fattori genetici nella suscettibilità individuale all'aterosclerosi coronarica 29
The common variants in the lipoprotein lipase (LPL) gene, but not those in the insulin receptor substrate-1 (IRS-1), the beta 3 adrenergic receptor (beta3AR) and the intestinal fatty acids binding protein-2 (FABP-2) genes influence the lipid phenotypic expression in familial combined hyperlipidemia 29
Frequency of carriers of autosomal recessive hypercholesterolemia (ARH) in the Sardinian population: Preliminary results 29
Prevalenza della colelitiasi: osservazioni preliminari su un campione di popolazione lavorativa femminile. 27
Atherogeniic dyslipidemia in metabolic syndrome, type 2 diabetes and familial combined hyperlipemia: lipid and lipoproteins profiling 27
S17 X LOSS OF FUNCTION (LOF) MUTATION IN ANGIOPOIETIN LIKE 3 (ANGPTL3) IS ASSOCIATED WITH INCREASED PLASMA LIPOPROTEIN LIPASE ACTIVITY AND CHANGES IN LIPOPROTEIN COMPOSITION 26
null 26
Efficacy and safety of atorvasatin vs.fenofibrate in familial combined hyperlipidemia (FCHL). A randomized, pilot, comparative study 25
Sovrappeso corporeo e pressione arteriosa in un campione di bambini in età scolare 23
Metodica gascromatografica per il dosaggio degli sterolo neutri fecali 23
The common polymorphisms in the lipoprotein lipase (LPL) gene in Italy: prevalence in the general population and effects on plasma lipids. 22
The cholesterol ester transfer protein (CETP) TaqIB variant, HDL cholesterol levels, cardiovascular risk and the efficacy of pravastatin treatment – an individual patient meta-analisis of 13,677 subjects 20
Short-term treatment with a lipid-lowering agent: diethylamino-ethyldextran (Dexide) 19
Clinical implications of monogenic versus polygenic hypercholesterolemia: long-term response to treatment, coronary atherosclerosis burden, and cardiovascular events 14
Autophagy in development and regeneration: role in tissue remodelling and cell survival 12
Totale 3.501
Categoria #
all - tutte 8.829
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.829


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019288 0 0 0 0 0 0 0 0 0 59 130 99
2019/2020791 102 23 8 24 71 102 128 76 87 112 42 16
2020/2021381 34 24 9 26 9 61 10 37 42 96 29 4
2021/2022743 1 43 62 21 88 24 16 61 61 61 182 123
2022/2023687 142 130 45 74 71 79 18 39 65 3 20 1
2023/2024306 53 44 7 19 31 104 4 21 3 20 0 0
Totale 3.501